Nanjing King-friend Biochemical Hits Day High with 6.14% Surge

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. has experienced a notable surge today, gaining 6.14% and reaching an intraday high of CNY 7.48. This performance stands in contrast to the China Shanghai Composite, which recorded a modest increase of 1.16% on the same day. Over the past week, Nanjing King-friend has shown a positive trend with a 2.54% increase, while the broader market has faced a decline of 2.14%. However, the company’s performance over the longer term reveals challenges, with a year-to-date decline of 19.6% and a significant drop of 34.3% over the past year. Despite the recent uptick, the stock has consistently underperformed against the benchmark, particularly over the last three years, where it has seen a decline of 44.62%. Financial metrics indicate a mixed picture, with a return on equity of 10.58% and a price-to-book ratio of 2.58. The company also boasts a dividend yield of 1.24%, reflecting its commitment to returning value to shareholders amidst fluctuating performance.